BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18936167)

  • 1. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
    Chabot C; Spring K; Gratton JP; Elchebly M; Royal I
    Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.
    Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I
    Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of DEP-1/PTPRJ on threonine 1318 regulates Src activation and endothelial cell permeability induced by vascular endothelial growth factor.
    Spring K; Lapointe L; Caron C; Langlois S; Royal I
    Cell Signal; 2014 Jun; 26(6):1283-93. PubMed ID: 24583284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
    J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
    Lamalice L; Houle F; Jourdan G; Huot J
    Oncogene; 2004 Jan; 23(2):434-45. PubMed ID: 14724572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT; Yen ML; Lin CY; Kuo ML
    Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.
    Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M
    Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R; Tan BK; Punn A; Chen J; Randeva HS
    Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.
    Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW
    Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation.
    Spring K; Chabot C; Langlois S; Lapointe L; Trinh NT; Caron C; Hebda JK; Gavard J; Elchebly M; Royal I
    Blood; 2012 Sep; 120(13):2745-56. PubMed ID: 22898603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
    Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2.
    Alonso V; de Gortázar AR; Ardura JA; Andrade-Zapata I; Alvarez-Arroyo MV; Esbrit P
    J Cell Physiol; 2008 Dec; 217(3):717-27. PubMed ID: 18651620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase.
    Jin ZG; Ueba H; Tanimoto T; Lungu AO; Frame MD; Berk BC
    Circ Res; 2003 Aug; 93(4):354-63. PubMed ID: 12893742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
    Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
    Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells.
    Pan S; World CJ; Kovacs CJ; Berk BC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):895-901. PubMed ID: 19359662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
    Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
    J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM1: a key regulator of vascular permeability.
    Nouvion AL; Oubaha M; Leblanc S; Davis EC; Jastrow H; Kammerer R; Breton V; Turbide C; Ergun S; Gratton JP; Beauchemin N
    J Cell Sci; 2010 Dec; 123(Pt 24):4221-30. PubMed ID: 21081647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein tyrosine phosphatase PTPRJ/DEP-1 contributes to the regulation of the Notch-signaling pathway and sprouting angiogenesis.
    Fournier P; Viallard C; Dejda A; Sapieha P; Larrivée B; Royal I
    Angiogenesis; 2020 May; 23(2):145-157. PubMed ID: 31598898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.